SUNation Files Draft Registration for Suniva Merger With $835 Million in Manufacturing Financing
Key Facts
SUNation Energy filed a confidential draft registration statement with the U.S. Securities and Exchange Commission concerning its merger with Suniva, beginning the regulatory process for the deal without implying SEC approval or completion of the merger. Under the merger announcement, a wholly owned subsidiary of SUNation will merge into Suniva, which will remain the surviving company and a wholly owned subsidiary of SUNation. The combined entity is expected to operate as Suniva, while SUNation remains listed on the Nasdaq Capital Market. But the legal structure alone does not reflect the expected allocation of economic control after closing. Under the consideration formula set out in the agreement, former Suniva shareholders are expected to own about 98.2% of the combined company, compared with about 1.8% for former SUNation shareholders. The percentages remain subject to adjustment based on SUNation’s net cash at closing.
The deal is built around expanding Suniva’s U.S. solar-cell manufacturing business, and the company announced that it completed a $835 million debt and equity financing raise on September 8, 2026, to support the expansion. The plan includes a new facility in Laurens County, South Carolina, with planned manufacturing capacity of 4.5 gigawatts of high-efficiency monocrystalline silicon cells. Suniva said the facility is expected to be completed in late 2027, with full operations targeted for 2028. The company’s operating facility in Norcross, Georgia, has manufacturing capacity of 1 gigawatt, according to its announcement. Once the planned expansion is complete, Suniva aims to raise its total U.S. manufacturing capacity to 5.5 gigawatts. The announced investment in the Laurens project is about $600 million, with 564 advanced-manufacturing jobs expected.
The companies revised some deal terms in September, including the minimum net cash SUNation must have at closing. The amendment raised the threshold from negative $1.5 million to negative $2.5 million, subject to potential adjustments related to capital raises. It also increased the number of authorized shares in SUNation’s charter from 1 billion to 1.5 billion. This change requires SUNation shareholder approval as part of the merger-related approvals. The revised cash threshold reflects that the expected consideration and ownership split are tied to SUNation’s financial position at closing. The percentages cited in the merger agreement may therefore change based on the final net-cash calculation.
The deal comes as SUNation faces year-over-year declines in residential solar demand and combined revenue, the company said in its second-quarter results. SUNation linked the decline to the loss of the federal residential 25D tax credit effective January 1, 2026. It said commercial, services and storage activities offset part of the impact. The company posted a net loss of $3.34 million in the second quarter of 2026, compared with a loss of $9.61 million in the same period of 2025 and $4.09 million in the first quarter of 2026. The company said the year-over-year second-quarter comparison was affected by a non-cash revaluation of warrants worth $7.5 million in the second quarter of 2025, which did not recur in 2026. SUNation shares closed at $2.05 on October 30, 2026, according to EL7 data.
Closing was targeted for the second half of 2026, but remains subject to shareholder approvals, the effectiveness of the registration statement with the Securities and Exchange Commission, Nasdaq approval and other customary closing conditions. The draft filing therefore does not establish that the deal will close within the targeted period or that the necessary approvals have been obtained. The merger agreement provides for the possibility of termination if the deal is not completed by January 30, 2027. The agreement allows for a potential 60-day extension in specified circumstances. The increase in authorized shares must also be submitted to SUNation shareholders as part of the deal-related approvals. The next steps remain tied to completing regulatory review, the shareholder vote and the satisfaction of closing conditions.